Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2007
by Università degli Studi dell'Insubria.
Recruitment status was Recruiting
Study NCT00564057 Information provided by Università degli Studi dell'Insubria
First Received on November 26, 2007. Last Updated on December 5, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Hypertension
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Vascular Diseases
Virus Diseases
Interventions listed in this trial
candesartan
lercanidipine
Additional drug interventions recognized in this trial
Antihypertensive Agents
Candesartan cilexetil
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Calcium Channel Blockers
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Università degli Studi dell'Insubria
Back to top of Main Content